Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis

Objective: to evaluate the impact of tocilizumab (TCZ) therapy on the level of acute-phase indicators, autoantibodies, and immunoglobulins (Ig) G, M, and A after 2, 4, 8, 12, and 24 weeks as compared to the clinical efficacy of TCZ using DAS 28, SDAI, and CDAI scores and to reveal the immunological...

Full description

Bibliographic Details
Main Authors: Anastasia Sergeyevna Avdeyeva, E N Aleksandrova, E Yu Panasyuk, A A Novikov, M V Cherkasova, E L Nasonov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2012-06-01
Series:Научно-практическая ревматология
Subjects:
das 28
cdai
m
a
rheumatoid arthritis
tocilizumab
sdai
erythrocyte sedimentation rate
c-reactive protein
igm/iga rheumatoid factors
anti-cyclic citrullinated peptide antibodies
anti-modified citrullinated vimentin antibodies
immunoglobulins g
Online Access:https://rsp.mediar-press.net/rsp/article/view/842

Internet

https://rsp.mediar-press.net/rsp/article/view/842

Similar Items